Showing 171-180 of 9754 results for "".
DermWireTV: AAD VMX Highlights, Upneeq Launches for Ptosis
https://practicaldermatology.com/topics/practice-management/dermwiretv-aad-vmx-highlights-upneeq-launches-for-ptosis/19931/The American Academy of Dermatology's VMX format delivers updates on a range of hot topics in dermatology, including an update on the COVID-19 dermatology vaccine registry from Esther Freeman, MD and teledermatology from Jules Lipoff, MD. Upneeq, a newly launched oxymetazoline eyedrop from RVL pharmRhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhofade-approved-sun-leaves-acne-behind-radiesse-turns-10/18552/The FDA has approved Allergan's Rhofade (Oxymetazoline 1%) cream for the topical treatment of persistent facial erythema associated with rosacea in adults. New research from Olay in collaboration with personal genetics company 23andMe shows that taking care of the skin may be the key to looking upGolden Achievement: Dr. Michael Gold on Lifetime Award at CSF 2016
https://practicaldermatology.com/topics/practice-management/golden-achievement-dr-michael-gold-on-lifetime-award-at-csf-2016/18712/Michael H. Gold, MD was recognized December 2016 at the Cosmetic Surgery Forum in Las Vegas with the Lifetime Contribution to Aesthetics Award by CSF Founder Joel Schlessinger, MD. Speaking about the award, Dr. Gold shares his perspective as a global educator and practitioner (Dr. Gold cofounded theLasers in Acne: Expanding the Options
https://practicaldermatology.com/topics/general-topics/lasers-in-acne-expanding-the-options/18745/By Abigail Waldman, MD and Seemal R. Desai, MDThe Nd-YAG (1064nm) laser can be used for acne—including cystic acne—and acne scarring. Dr. Waldman discusses the AAD's first-ever hands-on laser session and the role of the Nd-YAG laser in patient care.Advances in Laser Tattoo Removal
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-laser-tattoo-removal/18607/Laser tattoo removal continues to rise in popularity largely due to advances in technology and technique. In particular, the DeScribe Transparent PFD Patch has helped make tattoo removal treatment sessions more tolerable for patients and expedite clearance of tattoos. Jeremy A. Brauer, MD Director oSequencing Therapies for Long-Term Control of Atopic Dermatitis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/sequencing-therapies-for-long-term-control-of-atopic-dermatitis/48786/Christopher Bunick, MD, FAAD, talks about the six effective and safe advanced systemic therapies for atopic dermatitis and how to prescribe them for patients as early as possible by understanding the guidelines and the labels.Diet and AD: Can We Stop Leaky Skin?
https://practicaldermatology.com/topics/atopic-dermatitis/diet-and-ad-can-we-stop-leaky-skin/19545/New evidence elucidates the link between diet, atopic dermatitis, and food allergy and may point to opportunities to protect the skin in order to prevent allergy and AD. Peter Lio, MD reviews the latest science.Alma Lasers Soprano ICE
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/alma-lasers-soprano-ice/19242/Soprano ICE is the next generation hair removal laser from Alma Lasers. With Alma Lasers' patented SHR technology, the new ICE offers pain free hair removal.Laser Adoption in Dermatology
https://practicaldermatology.com/series/c-suite-chats/laser-adoption-dermatology/26535/Pavel Efremkin, PhD, Founder and CEO of Aerolase, discusses the state of the laser market in dermatology and the various applications of new technology in the field.DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-diagnosing-melanoma-using-deep-learning-model-new-adbry-approval/26445/In this week's DermWireTV, researchers develop a novel deep-learning model designed to more accurately diagnose melanoma; LEO Pharma receives a new approval for atopic dermatitis drug Adbry; and in our PA Perspectives segment, Andrew Mastro discusses how to build an inflammatory clinic.